Table 1.
Relationship between DEK protein expression and clinicopathological features of PDAC
| Characteristic | (n) | DEK expression | P value | |
|---|---|---|---|---|
| 136 | Low | High | ||
| Age | 0.139 | |||
| ≤58 | 72 | 28 | 44 | |
| >58 | 64 | 32 | 32 | |
| Gender | 0.248 | |||
| Man | 80 | 32 | 48 | |
| Women | 56 | 28 | 28 | |
| Tumor size | 0.038* | |||
| ≤3cm | 68 | 36 | 32 | |
| >3cm | 68 | 24 | 44 | |
| Differentiation | <0.001* | |||
| Poor | 60 | 4 | 56 | |
| Well and moderate | 76 | 56 | 20 | |
| Tumor Stage | 0.002* | |||
| Ⅰ,Ⅱ | 80 | 44 | 36 | |
| Ⅲ,Ⅳ | 56 | 16 | 40 | |
| Lymph node metastasis | 0.001* | |||
| NO | 68 | 40 | 28 | |
| YES | 68 | 20 | 48 | |
| Distant metastasis | 0.101 | |||
| M0 | 120 | 56 | 64 | |
| M1 | 16 | 4 | 12 | |
| CA19-9 | 0.099 | |||
| ≤37 IU/ml | 80 | 40 | 40 | |
| >37 IU/ml | 56 | 20 | 36 | |
* P < 0.05